Doxazosin
Doxazosin is an alpha blocker with two established roles represented in this catalogue: relaxing prostate and bladder muscle in benign prostatic hyperplasia, and relaxing blood vessels in high blood pressure. Both attached records contain doxazosin alone.
Doxazosin Tablets
Benign Prostatic Hyperplasia, Hypertension
1mg · 2mg · 4mg
Developed to mitigate urinary outflow obstruction to support muscle relaxation and alleviate strain during micturition.
Key points
- Doxazosin belongs to the alpha blocker class.
- Cardura and Doxazosin Tablets both list 1 mg, 2 mg and 4 mg.
- Its catalogue relationships span prostate symptoms and hypertension.
- Marked dizziness or fainting can occur after a first dose or dose increase.
One ingredient, two clinical contexts
In benign prostatic hyperplasia, relaxing smooth muscle can make urine flow more easily. In hypertension, relaxation of blood vessels reduces resistance to blood flow.
Cardura appears in prostate health, while the generic-name record is attached to bladder health. Those category paths organise the same active ingredient around the topics present in each product record.
Strengths and release wording
Cardura and Doxazosin Tablets each represent standard 1 mg, 2 mg and 4 mg tablets. Doxazosin also exists in extended-release formulations, but release type changes how a tablet is handled. No extended-release wording is attached to these two records.
Doxazosin can produce a pronounced fall in blood pressure after the first dose, after an increase or when treatment resumes after an interruption. Dizziness and fainting therefore have direct relevance to the medicine’s alpha-blocking action.